Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911852 | 12591185 | 2 | F | 20160301 | 20160321 | 20160726 | 20160727 | PER | US-UNITED THERAPEUTICS-UNT-2016-004730 | UNITED THERAPEUTICS | 56.00 | YR | M | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911852 | 12591185 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.0325 ?G/KG, CONTINUING | 926618 | 21272 | .032 | UG/KG | INJECTION | ||||||
| 125911852 | 12591185 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | 5 MG, QD | SBFP | 0 | 5 | MG | TABLET | QD | ||||||
| 125911852 | 12591185 | 3 | C | ADEMPAS | RIOCIGUAT | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 4 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 5 | C | FAMOTIDINE. | FAMOTIDINE | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 6 | C | LANOXIN | DIGOXIN | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 7 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 8 | C | LASIX | FUROSEMIDE | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 9 | C | COUMADIN | WARFARIN SODIUM | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 10 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 11 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 12 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | U | U | 0 | ||||||||||
| 125911852 | 12591185 | 13 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125911852 | 12591185 | 1 | Product used for unknown indication |
| 125911852 | 12591185 | 2 | Pulmonary hypertension |
| 125911852 | 12591185 | 3 | Product used for unknown indication |
| 125911852 | 12591185 | 4 | Product used for unknown indication |
| 125911852 | 12591185 | 5 | Product used for unknown indication |
| 125911852 | 12591185 | 6 | Product used for unknown indication |
| 125911852 | 12591185 | 7 | Product used for unknown indication |
| 125911852 | 12591185 | 8 | Product used for unknown indication |
| 125911852 | 12591185 | 9 | Product used for unknown indication |
| 125911852 | 12591185 | 10 | Product used for unknown indication |
| 125911852 | 12591185 | 11 | Product used for unknown indication |
| 125911852 | 12591185 | 12 | Product used for unknown indication |
| 125911852 | 12591185 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125911852 | 12591185 | Nasal congestion | |
| 125911852 | 12591185 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125911852 | 12591185 | 1 | 20151018 | 0 | ||
| 125911852 | 12591185 | 2 | 20160222 | 0 |